Jul 2026· Experimental Neurology· pp.
115950
· 0 citations
Medicine
TL;DR
In mice with conditional Arid1b haploinsufficiency in excitatory neurons, an increase in the rate of synaptic connectivity between excitatory neurons and reduced strength of excitatory synapses to parvalbumin (PV)-expressing inhibitory interneurons is found.
Abstract
Arid1b is a high confidence risk gene for autism spectrum disorder that encodes a subunit of a chromatin remodeling complex initially expressed in neuronal progenitors. Haploinsufficiency causes a broad range of social, behavioral, and intellectual disability phenotypes, including Coffin-Siris syndrome. Recent work suggests pathology is due to deficits in proliferation, survival, and synaptic development of cortical neurons. Here, we used transgenic mice to investigate how Arid1b dysfunction in cortical excitatory neurons impacts their intrinsic membrane properties, synaptic connectivity and physiology of local cortical circuits using paired whole-cell recordings, social behavior, and seizure susceptibility. We found that loss of both copies of Arid1b altered the proportions of different excitatory neuron cell-types in the superficial cortical layers; however, their intrinsic membrane properties were mostly unchanged. In mice with conditional Arid1b haploinsufficiency in excitatory neurons, we found an increase in the rate of synaptic connectivity between excitatory neurons and reduced strength of excitatory synapses to parvalbumin (PV)-expressing inhibitory interneurons. In the deep cortical layers, we found hyperpolarization of action potential threshold. Collectively, these data suggest an increase in the ratio of excitation to inhibition. However, we also found enhanced inhibition from PV interneurons to excitatory neurons that may rebalance this ratio. Indeed, Arid1b haploinsufficiency in excitatory neurons was insufficient to cause social deficits and seizure phenotypes observed in a preclinical germline haploinsufficient mouse model. Our data suggest that while excitatory neurons likely contribute to autistic phenotypes, pathology in these cells is not the primary cause.
These findings identify ankyrin-G as a molecular bridge between excitatory neuronal activity, synaptic structure, and myelin-associated protein expression, revealing a pathway by which ANK3 variants may contribute to neuropsychiatric disease.
Sehyoun Yoon, Marc Dos Santos, Natalia Khalatyan et al.· Proceedings of the National...· 0 citations
These findings establish DLG4 haploinsufficiency as a shared consequence of pathogenic DLG4 variants, while revealing additional variant-associated effects on neuronal structure and activity, rescued by AAV9-mediated neuronal restoration.
Dania Abdellatif, Mustafa Obeid, Rami I. Aqeilan· bioRxiv· 0 citations
A novel role for Foxg1 is identified in PV+ interneurons, providing new mechanistic insights into their vulnerability to SCZ, and pharmacological potentiation of mGluR3 activity alleviates behavioral deficits in Foxg1 conditional knockout mice.
Pengfei Jiang, Mingzhao Su, Xue-lai Zhou et al.· Neuroscience Bulletin· 0 citations
The results suggest that β-catenin deficiency in forebrain excitatory neurons leads to fear conditioning impairment, which could be contributed by the diminished excitatory synaptic transmission in PFC resulting from disrupted synaptic gene expression.
Luis Gustavo Hernandez Carballo, Rachel Senek, Ksenia Novototskaya-Vlasova et al.· Brain Communications· 0 citations
The first comprehensive human mechanistic model of PPP1R9A haploinsufficiency using an isogenic CRISPR/Cas9-engineered iPSC system differentiated into cortical neurons is established, providing a human-specific mechanistic framework linking reduced Neurabin I dosage to neurodevelopmental and psychiatric disease risk.
These findings identify Dlx5/6 as regulators of adult PV interneuron stability, linking extracellular matrix homeostasis to synaptic organization and cortical network dynamics, and provides a new mechanistic framework connecting Dlx5/6 function to PV-related pathological phenotypes, including neuropsychiatric disorders.